A middle-aged man with a troubled liver: Combination therapy in advanced (BCLC Stage C) hepatocellular carcinoma
Advanced hepatocellular carcinoma carries a bad prognosis with a survival of only few months. Barcelona Clinic Liver Cancer (BCLC) Guidelines recommended sorafenib monotherapy as the treatment modality for advanced BCLC Stage C disease, citing a two-month increase in survival rates. Here, we highli...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
GESDAV
2018-03-01
|
Series: | Archives of Clinical and Experimental Surgery |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=243853 |